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Introduction
Polylactic-co-glycolic acid (PLGA) is a synthetic copolymer of two different mono-
mers, lactic acid, and glycolic acid. It has a great deal of attention in research and 
development as an alternative biodegradable polymer which has constant biodegra-
dation rate, mechanical resistance, and regular individual chain geometry[1]. PLGA on 
hydrolysis of its ester linkages in the presence of water releases the monomers. These 
two monomers under normal physiological conditions are the by-products of various 
metabolic pathways in the body, hence minimum systemic toxicity. Higher the content 
of glycolide units in the PLGA, lower the time required for degradation. PLGA is a 
choice in the manufacturing of biomedical devices, i.e., grafts, sutures, implants, sur-
gical sealant films, prosthetic devices, micro and nanoparticles[2]. Specifically, PLGA 
is more useful for the designing of better pharmaceuticals formulations, i.e., the drug 
like simvastatin, amoxicillin, vancomycin, and minocycline loaded PLGA nanoparti-
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Polylactic-co-glycolic acid (PLGA) is a biodegradable copolymer. It has many applications in the pharmaceuticals and 
biomedical industries, but its degradation and stability is a major concern. The objective of this study was to evaluate 
the influence of the Trivedi Effect® on the physicochemical and thermal properties of PLGA using modern analytical 
techniques. The PLGA sample was divided into control and Biofield Energy Treated parts. The control sample did 
not obtain the Biofield Energy Treatment, whereas the treated PLGA was received the Trivedi Effect®-Consciousness 
Energy Healing Treatment remotely by a renowned Biofield Energy Healer, Alice Branton. The particle size values of 
the treated PLGA were increased by 8.97%(d10), 8.79%(d50), 4.72%(d90), and 6.61%{D(4,3)}; thus, the surface area of 
treated PLGA was significantly decreased by 6.84% compared with the control sample. The latent heat of evaporation 
and fusion of the treated PLGA were significantly increased by 29.60% and 230.93%, respectively compared with the 
control sample. The residue amount was significantly increased by 21.99% in the treated PLGA compared to the control 
sample. The maximum thermal degradation temperature of the treated PLGA was increased by 2.30% compared with 
the control sample. It was concluded that the Trivedi Effect®-Consciousness Energy Healing Treatment might have gen-
erated a new form of PLGA which may show better powder flowability, thermal stability, and minimise the hydrolysis 
of the ester linkages of PLGA.This improved quality of PLGA would be a better choice for the pharmaceutical formu-
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cles could be effective in sustaining drug release for a prolonged 
period[3-5]. The PLGA containing less than 50% glycolic acid 
units is soluble in most common organic solvents, such as chlo-
roform, dichloromethane, ethyl acetate, dioxane, acetone, and 
tetrahydrofuran. However, PLGA rich in glycolyl units 50% and 
higher is insoluble in most organic solvents[6,7]. In the absence of 
moisture, it has adequate heat stability[8]. The degradation and 
stability of PLGA is a major concern, which completely depends 
upon the monomer distribution pattern, chain-ends chemical 
composition, porosity, size, shape, and presence of additives 
(i.e., acidic/ basic compounds, plasticizers, or drugs), moisture, 
and temperature[9-11].
 Many Scientific study on the Trivedi Effect® (Biofield 
Energy Healing Treatment) has been claimed to have the signifi-
cant influence on the physicochemical, thermal, and behavioural 
properties (crystallite size, particle size, surface area, solubili-
ty, melting point, latent heat, etc.) of various object(s)[12-14]. The 
Trivedi Effect® is a natural and only scientifically proven phe-
nomenon in which a person can harness this inherently intelli-
gent energy from the Universe and transmit it anywhere on the 
planet through the possible mediation of neutrinos[15]. There is a 
unique para-dimensional electromagnetic field generated from 
the continuous movement of the electrically charged particles 
(i.e., ions, cells, etc.) inside the body. This electromagnetic field 
(A Putative Energy Field) exists around the body of every living 
organism known as the “Biofield”. The Biofield Energy Healers 
have the ability to harness the energy from the Universe and can 
transmit into any living or non-living object(s) around the earth. 
All over the world the Biofield based Energy Healing Therapies 
have been accepted and reported in many scientific journals with 
significant outcomes against various disease conditions[16,17]. 
The Biofield Energy Healing therapy has been recognized as a 
Complementary and Alternative Medicine (CAM) health care 
approach by the National Center of Complementary and Inte-
grative Health (NCCIH) with other therapies, medicines and 
practices such as yoga, Tai Chi, Qi Gong, homeopathy, chiro-
practic/osteopathic manipulation, meditation, acupressure, acu-
puncture, healing touch, hypnotherapy, movement therapy, natu-
ropathy, Ayurvedic medicine, cranial sacral therapy, traditional 
Chinese herbs and medicines, aromatherapy, Reiki, etc., that has 
been accepted by most of the U.S. population[18,19]. The Trive-
di Effect®-Consciousness Energy Healing Treatment (Biofield 
Energy Healing Treatment) also reported with their significant 
outcomes in different field of sciences i.e., material science[20,21], 
organic chemistry[22,23], nutraceutical/pharmaceutical scienc-
es[24,25], biotechnology[26,27], microbiology[28,29], agriculture[30,31], 
and medical science[32,33]. Therefore, the study was designed to 
evaluate the influence of the Trivedi Effect®-Consciousness En-
ergy Healing Treatment on PLGA using powder X-ray diffrac-
tion (PXRD), particle size analysis (PSA), differential scanning 
calorimetry (DSC) analytical techniques, and thermogravimetric 
analysis (TGA)/Differential thermogravimetric analysis (DTG).
Materials and Methods 
Chemicals and Reagents
The polylactic-co-glycolic acid (PLGA, 70:30) powder was pur-
chased from Changchun Hang Gai Biological Technology Co., 
Ltd., China. All other chemicals used during the experiments 
were of analytical grade available in India.
Consciousness Energy Healing Treatment Strategies
The test sample PLGA powder was divided into two parts. One 
part of the test sample was treated with the Trivedi Effect®-Con-
sciousness Energy Healing Treatment remotely under standard 
laboratory conditions for 3 minutes and known as a Biofield 
Energy Treated PLGA sample. The Biofield Energy Treatment 
was provided through the healer’s unique energy transmission 
process by the renowned Biofield Energy Healer, Alice Bran-
ton, USA, to one part of the test PLGA sample. Subsequently, 
the other part of the test sample was considered as a control/
untreated sample (Biofield Energy Treatment was not provided). 
Further, the control sample was treated with a “sham” healer for 
the comparison with the analytical results of the Biofield Ener-
gy Treated PLGA sample. The “sham” healer did not have any 
knowledge about the Biofield Energy Treatment. After all, the 
Biofield Energy Treated and untreated PLGA samples were kept 
in the sealed conditions and characterized using PXRD, PSA, 
DSC, and TGA analytical techniques. 
Characterization
The PSA, PXRD, DSC, and TGA analysis of PLGA were per-
formed. The PXRD analysis of PLGA powder sample was per-
formed with the help of Rigaku MiniFlex-II Desktop X-ray 
diffractometer (Japan)[34,35]. The average size of crystallites was 
calculated from PXRD data using the Scherrer’s formula (1)
G = kλ/βcosθ  (1)
 Where G is the crystallite size in nm, k is the equipment 
constant (0.94), λ is the radiation wavelength (0.154056 nm for 
Kα1 emission), β is the full-width at half maximum, and θ is the 
Bragg angle[36]. 
 The PSA was performed using Malvern Mastersizer 
2000, from the UK with a detection range between 0.01 µm to 
3000 µm using the wet method. Similarly, the DSC analysis of 
PLGA was performed with the help of DSC Q200, TA instru-
ments.  The TGA/DTG thermograms of PLGA were obtained 
with the help of TGA Q50 TA instruments[37,38]. 
 The % change in particle size, specific surface area 
(SSA), peak intensity, crystallite size, melting point, latent heat, 
weight loss and the maximum thermal degradation temperature 
(Tmax) of the Biofield Energy Treated sample was calculated 
compared with the control sample using the following equation 
2:
[ ]Treated - Control% change =   100
Control
×      (2)
Results and Discussion
Powder X-ray Diffraction (PXRD) Analysis 
PXRD study of the control and Biofield Energy Treated PLGA 
was performed to determine the crystalline pattern of the sam-
ples. The PXRD experimental results of the control and Biofield 
Energy Treated PLGA samples did not show sharp and intense 
peaks in the respective diffractograms (Figure 1). Thus, it was 
concluded that both samples were amorphous in nature and the 
Biofield Energy Treatment might not affect the crystallinity and 
pattern of the PLGA. 
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Figure 1: PXRD diffractograms of the control and Biofield Energy-
Treated polylactic-co-glycolic acid
Particle Size Analysis (PSA)
The PSA analysis of both the control and Biofield Energy Treat-
ed PLGA were performed, and the calculated results are present-
ed in Table 1.The particle size values of the control sample at 
d10, d50, d90, and D(4,3) were 123.36 µm, 393.83 µm, 864.9µm, 
and 451.581 µm, respectively. Similarly, the particle sizes of the 
Biofield Energy Treated PLGA at d10, d50, d90, and D(4,3) were 
134.42 µm, 428.42 µm, 905.69µm, and 481.43µm, respectively. 
Hence, the particle size values in Biofield Energy Treated PLGA 
was increased by 8.97%, 8.79%,4.72%, and 6.61% at d10, d50, 
d90, and D(4,3), respectively compared to the control sample (Ta-
ble 1). The specific surface area of the Biofield Energy Treated 
PLGA (0.0245m2/g) was decreased by 6.84% compared with the 
control sample (0.0263m2/g). Hence, it can be proposed that the 
Trivedi Effect®-Consciousness Energy Healing Treatment might 
reduce the internal molecular energy for increasing the particle 
size of PLGA sample. The increased particle size of a compound 
may help in enhancing the shape, appearance, and flowability of 
that compound[39,40]. Thus, the Biofield Energy Treatment might 
improve the powder flowability, the lower solubility of PLGA 
in the solvent. Lower solubility of the Biofield Energy Treated 
samplein water would be helpful to minimise the hydrolysis of 
the ester linkages in PLGA[2-5]. This improved quality would be 
a better choice for the pharmaceutical formulationsand biomed-
ical devices manufacturing industry using it as a raw material.
Table 1: Particle size distribution of the control and Biofield Energy 
Treated Polylactic-co-glycolic acid
Parameter d10 (µm) d50 (µm) d90 (µm) D ( 4 , 3 )
(µm)
SSA(m2/g)
Control 123.36 393.83 864.9 451.581 0.0263
Biofield  
Treated
134.42 428.42 905.69 481.43 0.0245
Percent 
change* (%) 
8.97 8.78 4.72 6.61 -6.84
d10, d50, and d90: particle diameter corresponding to 10%, 50%, and 90% 
of the cumulative distribution, D(4,3): the average mass-volume diam-
eter, and SSA: the specific surface area. 
*denotes the percentage change in the Particle size distribution of the 
Biofield Energy Treated sample with respect to the control sample.
Differential Scanning Calorimetry (DSC) Analysis
 The thermal analysis of both control and Biofield Ener-
gy Treated samples has been performed to evaluate the impact of 
the Trivedi Effect® on the thermal behavior of PLGA. The ther-
mograms of both the samples showed two endothermic peaks. 
The control PLGA sample showed the sharp endothermic peaks 
at 60.94°C and 335.11°C in the thermogram (Figure 2). Similar-
ly, the Biofield Energy Treated PLGA sample showed the sharp 
endothermic peaks at 60.95°C and 328.4°Cin the thermogram 
(Figure 2). The 1st endothermic peak was due to the evaporation 
of the trapped water molecule from the sample, whereas the 2nd 
large endothermic pick was due to the melting of PLGA. The ob-
served DSC thermograms patterns were well matched with the 
literature data[1]. The evaporation and melting temperature of the 
Biofield Energy Treated PLGA were slightly altered by 0.02% 
and -2.00%, respectively compared with the control sample 
(Table 2). However, the latent heat of evaporation (∆Hevaporation) 
and latent heat of fusion (∆Hfusion) of the Biofield Energy Treated 
PLGA were significantly increased by 29.60% and 230.93%, re-
spectively compared with the control sample (Table 2). Although 
the evaporation and melting temperature were altered, but the 
heat energy required by the Biofield Energy Treated PLGA for 
the evaporation and melting was significantly increased com-
pared to the control sample. Therefore, it can be assumed that 
the thermal stability of the Biofield Energy Treated PLGA was 
increased compared to the control sample. Any change in the 
molecular chains, and the crystal structure influence the latent 
heat of fusion[41]. Therefore, Alice’s Biofield Energy Treatment 
could have disturbed the molecular chains and crystal structure 
of PLGA which lead to the increased thermal stability of the 
Biofield Energy Treated sample compared to the control sample.
Table 2: DSC data for both control and Biofield Energy Treated sam-
ples of Polylactic-co-glycolic acid
Sample Melting point (°C) ∆H(J/g)
1st Peak 2nd Peak Evaporation Melting
Control Sample 60.94 335.11 5.54 66.54
Biofield Energy 
Treated
60.95 328.4 7.18 220.2
% Change* 0.02 -2.00 29.60 230.93
ΔH: Latent heat of evaporation/fusion, *denotes the percentage change 
of the Biofield Energy Treated PLGA with respect to the control sample.
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Figure 2: DSC thermograms of the control and Biofield Energy Treated 
Polylactic-co-glycolic acid
Thermal Gravimetric Analysis (TGA)/ Differential thermo-
gravimetric analysis (DTG)
The TGA/DTG thermograms of the control and Biofield Energy 
Treated PLGA samples are displayed in Figures 3 and 4. Both 
the thermograms showed one step of the degradation process. 
The total weight loss in the Biofield Energy Treated PLGA 
(96.39%) was decreased by 0.67% compared with the control 
sample (97.04%). Therefore, the residue amount was 21.99% 
more in the Biofield Energy Treated PLGA compared to the con-
trol sample (Table 3). 
Figure 3: TGA thermograms of the control and Biofield Energy Treated 
Polylactic-co-glycolic acid
 
Figure 4: DTG thermograms of the control and Biofield Energy Treat-
ed Polylactic-co-glycolic acid
Table 3: TGA/DTG data of the control and Biofield Energy Treated 
samples of Polylactic-co-glycolic acid
Sample
TGA DTG
Tmax (°C)Total weight loss (%) Residue %
Control 97.04 2.96 295.91
Biofield Energy 
Treated 96.39 3.61 302.73
% Change* -0.67 21.99 2.30
*denotes the percentage change of the Biofield Energy Treated sample 
with respect to the control sample, Tmax = the temperature at which 
maximum weight loss takes place in TG or peak temperature in DTG.
 Similarly, the DTG thermograms of the control and 
Biofield Energy Treated PLGA exhibited one sharp peak (Fig-
ure 4). The maximum thermal degradation temperature (Tmax) 
of the Biofield Energy Treated PLGA was increased by 2.30% 
compared with the control sample. Overall, TGA/DTG thermal 
analysis revealed that the thermal stability of the Biofield Energy 
Treated PLGA was increased compared with the control sample.
Conclusions
The Trivedi Effect®-Consciousness Energy Healing Treatment 
have a significant impact on the particle size, surface area, and 
thermal behaviors of PLGA. The particle size values of the Bio-
field Energy Treated PLGA powder sample at d10, d50, d90, and 
D(4,3) were increased by 8.97%, 8.79%, 4.72%, and 6.61%, 
respectively compared to the control sample. Therefore, the sur-
face area of the Biofield Energy Treated PLGA was significant-
ly decreased by 6.84% compared with the control sample. The 
∆Hevaporation and ∆Hfusion of the Biofield Energy Treated PLGA 
were significantly increased by 29.60% and 230.93%, respec-
tively compared with the control sample. The residue amount 
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was 21.99% more in the Biofield Energy Treated PLGA com-
pared to the control sample. The Tmax of the Biofield Energy 
Treated PLGA was increased by 2.3% compared with the con-
trol sample. The Trivedi Effect®-Consciousness Energy Healing 
Treatment might have introduced a new polymorphic form of 
PLGA which may show better powder flowability and minimise 
the hydrolysis of the ester linkages of PLGA. This improved 
quality of PLGA would be a better choice for the pharmaceutical 
formulations (i.e., the drug like simvastatin, amoxicillin, vanco-
mycin, and minocycline loaded PLGA nanoparticles) and man-
ufacturing of biomedical devices, i.e., grafts, sutures, implants, 
surgical sealant films, prosthetic devices, micro and nanoparti-
cles in the industry using it as a raw material.
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